Literature DB >> 21741700

Urinary incontinence in men after formal one-to-one pelvic-floor muscle training following radical prostatectomy or transurethral resection of the prostate (MAPS): two parallel randomised controlled trials.

Cathryn Glazener1, Charles Boachie, Brian Buckley, Claire Cochran, Grace Dorey, Adrian Grant, Suzanne Hagen, Mary Kilonzo, Alison McDonald, Gladys McPherson, Katherine Moore, John Norrie, Craig Ramsay, Luke Vale, James N'Dow.   

Abstract

BACKGROUND: Urinary incontinence is common immediately after prostate surgery. Men are often advised to do pelvic-floor exercises, but evidence to support this is inconclusive. Our aim was to establish if formal one-to-one pelvic floor muscle training reduces incontinence.
METHODS: We undertook two randomised trials in men in the UK who were incontinent 6 weeks after radical prostatectomy (trial 1) or transurethral resection of the prostate (TURP; trial 2) to compare four sessions with a therapist over 3 months with standard care and lifestyle advice only. Randomisation was by remote computer allocation. Our primary endpoints, collected via postal questionnaires, were participants' reports of urinary incontinence and incremental cost per quality-adjusted life year (QALY) after 12 months. Group assignment was masked from outcome assessors, but this masking was not possible for participants or caregivers. We used intention-to-treat analyses to compare the primary outcome at 12 months. This study is registered, number ISRCTN87696430.
FINDINGS: In the intervention group in trial 1, the rate of urinary incontinence at 12 months (148 [76%] of 196) was not significantly different from the control group (151 [77%] of 195; absolute risk difference [RD] -1·9%, 95% CI -10 to 6). In trial 2, the difference in the rate of urinary incontinence at 12 months (126 [65%] of 194) from the control group was not significant (125 [62%] of 203; RD 3·4%, 95% CI -6 to 13). Adjusting for minimisation factors or doing treatment-received analyses did not change these results in either trial. No adverse effects were reported. In both trials, the intervention resulted in higher mean costs per patient (£180 and £209 respectively) but we did not identify evidence of an economically important difference in QALYs (0·002 [95% CI -0·027 to 0·023] and -0·00003 [-0·026 to 0·026]).
INTERPRETATION: In settings where information about pelvic-floor exercise is widely available, one-to-one conservative physical therapy for men who are incontinent after prostate surgery is unlikely to be effective or cost effective. The high rates of persisting incontinence after 12 months suggest a substantial unrecognised and unmet need for management in these men. FUNDING: National Institute of Health Research, Health Technology Assessment (NIHR HTA) Programme.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21741700     DOI: 10.1016/S0140-6736(11)60751-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  29 in total

Review 1.  Focusing on sexual rehabilitation besides penile rehabilitation following radical prostatectomy is important.

Authors:  Daphné Vanderhaeghe; Maarten Albersen; Emmanuel Weyne
Journal:  Int J Impot Res       Date:  2021-03-22       Impact factor: 2.896

Review 2.  [Urinary incontinence after radical prostatectomy : Possibilities of conservative management].

Authors:  A Borkowetz
Journal:  Urologe A       Date:  2018-10       Impact factor: 0.639

3.  Is Pelvic Floor Muscle Training Effective for Men With Poststroke Lower Urinary Tract Symptoms? A Single-Blinded Randomized, Controlled Trial.

Authors:  Sigrid Tibaek; Gunvor Gard; Christian Dehlendorff; Helle K Iversen; Fin Biering-Soerensen; Rigmor Jensen
Journal:  Am J Mens Health       Date:  2015-10-18

4.  New concept for treating urinary incontinence after radical prostatectomy with radiofrequency: phase 1 clinical trial.

Authors:  Danielle Santana Macêdo Sodré; Plínio Roberto Souza Sodré; Cristina Brasil; Alcina Teles; Matheus Dória; Luiz Eduardo Café; Patrícia Lordelo
Journal:  Lasers Med Sci       Date:  2019-04-15       Impact factor: 3.161

Review 5.  Conservative management for postprostatectomy urinary incontinence.

Authors:  Coral A Anderson; Muhammad Imran Omar; Susan E Campbell; Kathleen F Hunter; June D Cody; Cathryn M A Glazener
Journal:  Cochrane Database Syst Rev       Date:  2015-01-20

Review 6.  Current management strategy of treating patients with erectile dysfunction after radical prostatectomy: a systematic review and meta-analysis.

Authors:  Dechao Feng; Cai Tang; Shengzhuo Liu; Yubo Yang; Ping Han; Wuran Wei
Journal:  Int J Impot Res       Date:  2020-10-24       Impact factor: 2.896

7.  Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT.

Authors:  Lynda Constable; Paul Abrams; David Cooper; Mary Kilonzo; Nikki Cotterill; Chris Harding; Marcus J Drake; Megan N Pardoe; Alison McDonald; Rebecca Smith; John Norrie; Kirsty McCormack; Craig Ramsay; Alan Uren; Tony Mundy; Cathryn Glazener; Graeme MacLennan
Journal:  Health Technol Assess       Date:  2022-08       Impact factor: 4.106

8.  [Psychosomatic primary care for urinary incontinence].

Authors:  U Hohenfellner
Journal:  Urologe A       Date:  2015-01       Impact factor: 0.639

9.  Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers.

Authors:  Jonathan A Cook; Jenni Hislop; Douglas G Altman; Peter Fayers; Andrew H Briggs; Craig R Ramsay; John D Norrie; Ian M Harvey; Brian Buckley; Dean Fergusson; Ian Ford; Luke D Vale
Journal:  Trials       Date:  2015-01-15       Impact factor: 2.279

10.  Use of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery.

Authors:  Chen-Pang Hou; Tzu-Yu Chen; Chia-Chi Chang; Yu-Hsiang Lin; Phei-Lang Chang; Chien-Lun Chen; Yu-Chao Hsu; Ke-Hung Tsui
Journal:  Clin Interv Aging       Date:  2013-06-06       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.